RxSight（股票代码：RXST）今日盘中股价暴跌49.49%，引发市场广泛关注。这家眼科医疗设备公司的股价大幅下挫，主要源于其公布的业绩预期不及市场预期。
据报道，RxSight大幅下调了2025年的销售预期。公司将全年销售额预期从此前的1.6亿美元至1.75亿美元区间，下调至1.2亿美元至1.3亿美元之间，调整幅度超过25%。这一新预期远低于分析师平均预期的1.676亿美元。此外，公司还发布了令人失望的第二季度初步销售数据，预计约为3360万美元，显著低于分析师预计的3980万美元。
摩根大通分析师对此表示担忧，认为这反映出上季度首次出现的负面趋势持续恶化，而非改善。他们指出，这一趋势可能会持续到下半年，目前尚未看到明确的解决方案。这一系列消息引发了投资者对RxSight未来增长前景的担忧，导致股价大幅下挫。
此次股价暴跌给RxSight带来了沉重打击。截至目前，该公司股价今年累计下跌已超过60%，显示出投资者对其业务前景信心的严重动摇。未来RxSight能否扭转局面，重新赢得市场信心，将是投资者密切关注的焦点。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.